CRIS - a leader in regenerative medicine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS - a leader in regenerative medicine

CRIS 1.480

-0.7%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: scott_jiminez who wrote (1)	11/21/2000 11:58:33 PM
From: Spekulatius	of 2

Regenerative CNS is a very early stage research field and bold claims sort of make me suspicious. Right now, i do not like the fact that they have made a secondary share offering with a 15% below a depressed share price. My guess would be that in a weak market, we will see the shares fall below the price for the secondary (9$), which doesn't bode well for an investment right now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext